Donald Trump announced a historic move that could fundamentally change the situation in the U
S. healthcare market and significantly impact the global pharmaceutical industry. On his social media platforms, particularly on Truth Social, the former U.S. president revealed his intention to sign an executive order that would allow for a dramatic reduction in prescription drug prices in the country—by an incredible 30–80%. According to him, this decision will become one of the most important in the recent history of American medicine and healthcare. According to Trump, one of the main reasons for this step was his surprise at the fact that Americans were paying five or even ten times more for the same medications produced by the same factories compared to their counterparts in other countries. “We realized it was time to right this injustice. the United States must have access to the same affordable prices as other countries,” the former president emphasized. He also pointed out that signing this executive order would have a far-reaching impact not only on the domestic expenses of American citizens but also on the global pharmaceutical market. Trump highlighted that, according to his plan, global drug prices would increase in other parts of the world, which, in his view, would help balance the situation across the entire pharmaceutical industry and eliminate unjustified disparities. Discussing the specific benefits of the new executive order, Trump mentioned that its signing would enable the U.S. to reduce healthcare costs to levels previously considered unattainable. He estimates that this could save the country’s budget billions of dollars—referred to as “trillions of dollars”—which could be redirected toward other important social programs and infrastructure development. Overall, according to the former White House chief, this document will usher in a new era in the field of healthcare services in the U.S., make medicines more accessible to ordinary citizens, and increase government control over pricing in the pharmaceutical sector. The opposition leader predicts that this move will trigger a true revolutionary shift in the healthcare system and believes its effects will be felt not only in the United States but globally as well. However, not everyone is pleased. Some experts and critics are already questioning the realistic possibility of such rapid and radical price reductions and warn of potential negative consequences for the international medical drug market. Nevertheless, Trump is confident in the correctness and necessity of this step and urges Americans to expect positive changes soon.